Differentiating pulmonary hypertension associated with protein kinase inhibitors.

cancer dasatinib protein kinase pulmonary arterial hypertension tyrosine kinase

Journal

Pulmonary circulation
ISSN: 2045-8932
Titre abrégé: Pulm Circ
Pays: United States
ID NLM: 101557243

Informations de publication

Date de publication:
Apr 2022
Historique:
received: 16 12 2021
revised: 14 03 2022
accepted: 25 03 2022
entrez: 7 7 2022
pubmed: 8 7 2022
medline: 8 7 2022
Statut: epublish

Résumé

Protein kinase inhibitors (PKIs) have been implicated in pulmonary vascular toxicities including risk factors for at least three of the five World Health Organization groups of pulmonary hypertension (PH). These toxicities include direct drug-induced pulmonary arterial hypertension, an increase in cardiomyopathies, and an increase in interstitial lung disease. On- and off-target toxicities are common within multitargeted PKIs leading to cardiopulmonary toxicities. This review highlights the incidence, possible mechanisms, and management strategies for each group of possible PKI-induced PH. Future identification and clarification of protein kinase pathways for both mechanisms of toxicity and pathophysiology for PH could lead to improvements in patient care in oncology and pulmonary vascular diseases.

Identifiants

pubmed: 35795494
doi: 10.1002/pul2.12075
pii: PUL212075
pmc: PMC9248793
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

e12075

Informations de copyright

© 2022 The Authors. Pulmonary Circulation published by John Wiley & Sons Ltd on behalf of Pulmonary Vascular Research Institute.

Déclaration de conflit d'intérêts

The authors declare no conflicts of interest.

Références

Circulation. 2012 May 1;125(17):2128-37
pubmed: 22451584
Invest New Drugs. 2019 Apr;37(2):384-400
pubmed: 30203136
JACC Clin Electrophysiol. 2018 Dec;4(12):1491-1500
pubmed: 30573111
Pulm Circ. 2020 Aug 21;10(3):2045894020936913
pubmed: 32913629
Lancet. 2007 Dec 15;370(9604):2011-9
pubmed: 18083403
Pharmacol Res. 2020 Feb;152:104609
pubmed: 31862477
Eur Respir J. 2013 Jan;41(1):85-95
pubmed: 22523355
J Am Heart Assoc. 2020 Aug 4;9(15):e015992
pubmed: 32750312
Leukemia. 2006 Jun;20(6):1162-4
pubmed: 16598305
Eur J Prev Cardiol. 2018 Mar;25(5):482-494
pubmed: 29376753
Circulation. 2008 Jul 1;118(1):84-95
pubmed: 18591451
J Am Coll Cardiol. 2016 Mar 29;67(12):1499-1500
pubmed: 27012411
Circ Heart Fail. 2018 Mar;11(3):e004408
pubmed: 29664405
Nat Rev Drug Discov. 2018 May;17(5):353-377
pubmed: 29545548
J Am Heart Assoc. 2020 Sep 15;9(18):e018403
pubmed: 32893704
J Clin Oncol. 2015 Dec 10;33(35):4210-8
pubmed: 26371140
N Engl J Med. 2021 Jan 28;384(4):325-334
pubmed: 33440084
Cancer Sci. 2014 Dec;105(12):1584-90
pubmed: 25287435
Eur Respir J. 2019 Jan 24;53(1):
pubmed: 30545980
Eur Respir J. 2021 Dec 2;58(6):
pubmed: 34588195
Eur Respir J. 2019 Jan 24;53(1):
pubmed: 30552088
Eur Respir J. 2017 Jul 27;50(1):
pubmed: 28751413
JACC CardioOncol. 2019 Sep 24;1(1):24-36
pubmed: 34396159
Pulm Circ. 2017 Oct-Dec;7(4):808-812
pubmed: 28914582
Circulation. 2016 Jul 5;134(1):73-90
pubmed: 27358439
Eur Respir J. 2019 Jan 24;53(1):
pubmed: 30545968
Eur Respir J. 2019 Jan 24;53(1):
pubmed: 30545978
Eur Heart J. 2016 Jan 1;37(1):67-119
pubmed: 26320113
Eur Respir J. 2016 Feb;47(2):676-9
pubmed: 26743481
Curr Cardiovasc Risk Rep. 2021;15(1):2
pubmed: 33224405
Blood. 2019 Nov 28;134(22):1919-1928
pubmed: 31582362
Circ Cardiovasc Qual Outcomes. 2018 Feb;11(2):e003973
pubmed: 29444925
Chest. 2019 Mar;155(3):565-586
pubmed: 30660783
Br J Cancer. 2004 Aug;91 Suppl 2:S24-30
pubmed: 15340375
Rinsho Ketsueki. 2016 Aug;57(8):999-1003
pubmed: 27599415
N Engl J Med. 2015 Aug 27;373(9):834-44
pubmed: 26308684
Cancer Treat Rev. 2017 Feb;53:120-127
pubmed: 28104567
Cardiovasc Res. 2011 Feb 1;89(2):410-8
pubmed: 20935166
J Stroke Cerebrovasc Dis. 2020 Sep;29(9):105085
pubmed: 32807481
Lancet Respir Med. 2019 Sep;7(9):780-790
pubmed: 31416769
Eur Heart J. 2016 Sep 21;37(36):2768-2801
pubmed: 27567406
Circulation. 2016 Nov 15;134(20):1519-1531
pubmed: 27821538
JACC CardioOncol. 2020 Mar 17;2(1):123-126
pubmed: 34396217
Eur Respir J. 2020 Oct 29;56(4):
pubmed: 32527740
Clin Cancer Res. 2004 Feb 15;10(4):1212-8
pubmed: 14977817
JACC CardioOncol. 2020 Dec 15;2(5):795-799
pubmed: 34396296
Eur Respir J. 2007 Oct;30(4):715-21
pubmed: 17626111
Eur Respir J. 2016 Nov;48(5):1514-1516
pubmed: 27660511
Respiration. 2013;85(6):456-63
pubmed: 23257350
Nat Biotechnol. 2011 Oct 30;29(11):1046-51
pubmed: 22037378
J Clin Invest. 2016 Sep 1;126(9):3207-18
pubmed: 27482885
N Engl J Med. 2005 Sep 29;353(13):1412-3
pubmed: 16192491
Chest. 2014 Aug;146(2):449-475
pubmed: 24937180
J Clin Invest. 2005 Oct;115(10):2811-21
pubmed: 16200212
Drug Saf. 2016 Nov;39(11):1073-1091
pubmed: 27534751
J Thorac Oncol. 2020 Jul;15(7):1190-1199
pubmed: 32135189
Methods Enzymol. 2014;548:1-21
pubmed: 25399640
Eur Respir J. 2019 Jan 24;53(1):
pubmed: 30545974
Ann Intern Med. 2013 May 7;158(9):641-9
pubmed: 23648946
J Thorac Oncol. 2019 Feb;14(2):e38-e40
pubmed: 30683298
Chest. 2005 Oct;128(4):2393-9
pubmed: 16236900
Arterioscler Thromb Vasc Biol. 2020 Feb;40(2):301-308
pubmed: 31875699
Eur Respir J. 2015 Nov;46(5):1370-7
pubmed: 26250495
Circulation. 2013 Mar 12;127(10):1128-38
pubmed: 23403476
Hypertension. 2018 Feb;71(2):e1-e8
pubmed: 29279311
Eur Respir J. 2016 Nov;48(5):1517-1519
pubmed: 27799395
Eur Respir J. 2021 May 13;57(5):
pubmed: 33446610
Pulm Circ. 2019 Jul 5;:2045894019865704
pubmed: 31274047
JACC Basic Transl Sci. 2016 Dec 26;1(7):684-686
pubmed: 30167550
Eur Respir J. 2019 May 9;53(5):
pubmed: 31072877
Semin Nephrol. 2010 Nov;30(6):591-601
pubmed: 21146124
J Am Coll Cardiol. 2015 May 12;65(18):1976-97
pubmed: 25953750
Int J Hematol. 2012 Jul;96(1):132-5
pubmed: 22639052
Respir Res. 2019 Jun 6;20(1):111
pubmed: 31170998
Oncologist. 2013;18(8):900-8
pubmed: 23918069
Clin Cancer Res. 2017 Jul 15;23(14):3601-3609
pubmed: 28196874
Eur Respir J. 2019 May 9;53(5):
pubmed: 30846469
Heart. 2012 Dec;98(24):1805-11
pubmed: 22760869
Circulation. 2020 Dec 22;142(25):2443-2455
pubmed: 33092403
Eur Respir J. 2018 Jan 18;51(1):
pubmed: 29348177

Auteurs

Joshua A Jacobs (JA)

Department of Pharmacy University of Utah Health Salt Lake City Utah USA.

Eiman Jahangir (E)

Division of Cardiovascular Medicine, Department of Medicine Vanderbilt University Nashville Tennessee USA.

John J Ryan (JJ)

Division of Cardiovascular Medicine, Department of Medicine University of Utah Salt Lake City Utah USA.

Classifications MeSH